…
Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social. It also offers secure software development lifecycles, data classification, and third-party penetration testing services. The company was founded in 2008 and is based in Dublin, Ireland.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Oneview Healthcare plc provides a cloud-based patient engagement and clinical workflow platform for hospitals, enabling bedside entertainment, education, telehealth and EMR integration. Long-term growth could be supported by hospital digital transformation, rising telehealth and recurring SaaS contracts and international expansion, which may make its enterprise platform appealing to investors.
Material risks include competition from large health‑IT vendors, execution and client adoption risk, concentration in a limited number of hospital customers and contracts, regulatory and data‑privacy requirements (including HIPAA), and potential funding or cash‑flow constraints.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -12.46M | -10.77M | -8.88M | -10.92M | -8.13M |
| Net income | -12.51M | -10.84M | -8.93M | -10.87M | -8.19M |
| Selling general administrative | 7.26M | 3.48M | 3.07M | 3.54M | 3.30M |
| Selling and marketing expenses | - | 4.03M | 3.13M | 3.92M | 2.28M |
| Gross profit | 7.12M | 6.67M | 6.16M | 5.35M | 5.31M |
| Reconciled depreciation | - | 0.52M | 0.49M | 0.67M | 0.68M |
| Ebit | -10.99M | -11.36M | -8.37M | -10.76M | -8.01M |
| Ebitda | -10.48M | -11.26M | -7.88M | -10.09M | -7.33M |
| Depreciation and amortization | 0.51M | 0.10M | 0.49M | 0.67M | 0.68M |
| Operating income | -10.99M | -11.36M | -8.37M | -10.76M | -8.01M |
| Other operating expenses | 22.92M | 21.25M | 17.77M | 21.78M | 18.55M |
| Interest expense | 1.54M | 0.15M | 0.52M | 0.16M | 0.12M |
| Tax provision | 0.05M | 0.06M | 0.05M | -0.06M | 0.06M |
| Interest income | 1.52M | 0.13M | 0.01M | 0.06M | 0.12M |
| Net interest income | - | -0.02M | -0.51M | -0.10M | 0.00M |
| Income tax expense | 0.05M | 0.06M | 0.05M | -0.06M | 0.06M |
| Total revenue | 11.93M | 9.89M | 9.40M | 8.92M | 9.73M |
| Total operating expenses | 18.11M | 18.03M | 14.54M | 18.21M | 14.12M |
| Cost of revenue | 4.81M | 3.22M | 3.23M | 3.58M | 4.42M |
| Total other income expense net | -1.47M | 0.59M | -0.51M | -0.16M | -0.12M |
| Net income from continuing ops | - | -10.84M | -8.93M | -10.87M | -8.19M |
| Net income applicable to common shares | -12.59M | -10.84M | -8.93M | -10.87M | -8.19M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 15.49M | 25.96M | 21.92M | 12.75M | 21.09M |
| Intangible assets | 0.67M | 0.72M | 0.49M | 0.26M | 0.48M |
| Other current assets | 0.68M | 1.99M | 0.43M | 0.24M | 0.31M |
| Total liab | 11.84M | 12.71M | 12.78M | 10.50M | 11.19M |
| Total stockholder equity | 3.65M | 13.25M | 9.14M | 2.26M | 9.90M |
| Other current liab | 2.91M | 8.55M | - | 6.07M | 9.08M |
| Common stock | 0.77M | 0.76M | - | 0.53M | 120.59M |
| Capital stock | - | 0.76M | 0.67M | 0.53M | 120.59M |
| Retained earnings | -147.36M | -141.14M | -131.65M | -123.76M | -113.78M |
| Other liab | - | - | - | 2.81M | 0.05M |
| Other assets | - | - | - | 0.64M | 0.60M |
| Cash | 4.60M | 13.83M | 11.55M | 6.41M | 15.18M |
| Cash and equivalents | 4.60M | - | - | 6.41M | 15.18M |
| Total current liabilities | 9.81M | 10.12M | 11.74M | 7.32M | 10.29M |
| Current deferred revenue | 5.44M | - | - | - | - |
| Net debt | -2.61M | -12.68M | - | -5.87M | -13.97M |
| Short term debt | 0.23M | 0.25M | - | 0.17M | 0.37M |
| Short long term debt total | 1.99M | 1.15M | - | 0.54M | 1.20M |
| Other stockholder equity | 147.37M | 147.32M | - | 0.01M | 3.09M |
| Property plant equipment | 1.06M | - | - | 0.61M | 1.28M |
| Total current assets | 12.75M | 23.21M | 19.93M | 11.24M | 18.72M |
| Net tangible assets | - | - | - | 1.99M | 9.42M |
| Net receivables | 4.60M | 4.25M | 2.52M | 1.70M | 1.54M |
| Inventory | 2.87M | 3.15M | 2.24M | 1.23M | 0.69M |
| Accounts payable | 1.24M | 1.32M | 1.27M | 1.07M | 0.84M |
| Accumulated other comprehensive income | 2.87M | 6.31M | - | 125.48M | 3.09M |
| Treasury stock | - | - | - | - | -0.00M |
| Non currrent assets other | 1.01M | 0.89M | 0.46M | 0.64M | 0.60M |
| Non current assets total | 2.74M | 2.74M | 1.99M | 1.52M | 2.37M |
| Capital lease obligations | - | 1.15M | 0.94M | 0.54M | 1.20M |
| Long term debt total | 0.88M | - | - | 0.37M | 0.84M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.46M | -0.52M | -0.04M | -0.07M |
| Change to liabilities | - | - | - | -0.31M | 1.36M |
| Total cashflows from investing activities | -0.12M | -0.46M | -0.52M | -0.04M | -0.07M |
| Net borrowings | - | - | - | -0.32M | -0.29M |
| Total cash from financing activities | -0.29M | 13.14M | 13.04M | -0.10M | 12.22M |
| Net income | -12.51M | -10.84M | -14.47M | -10.87M | -8.19M |
| Change in cash | -8.54M | 2.28M | 5.14M | -8.77M | 8.37M |
| Begin period cash flow | 13.14M | 11.55M | 6.41M | 15.18M | 6.80M |
| End period cash flow | 4.60M | 13.83M | 11.55M | 6.41M | 15.18M |
| Total cash from operating activities | -8.32M | -10.47M | -7.26M | -8.91M | -4.03M |
| Issuance of capital stock | - | 13.32M | 13.84M | 0.31M | 13.38M |
| Depreciation | 0.51M | 0.54M | 0.50M | 0.67M | 0.68M |
| Other cashflows from investing activities | - | -0.40M | -0.40M | - | - |
| Change to inventory | 0.28M | -0.91M | -1.01M | -0.82M | -0.71M |
| Change to account receivables | 1.10M | -1.11M | -1.72M | -1.12M | 2.09M |
| Sale purchase of stock | 0.00M | 13.32M | -0.55M | -0.09M | -0.87M |
| Other cashflows from financing activities | -0.29M | 13.32M | -0.25M | -0.32M | -0.29M |
| Change to netincome | - | - | - | 2.87M | 1.23M |
| Capital expenditures | 0.06M | 0.06M | 0.52M | 0.04M | 0.07M |
| Change in working capital | -0.08M | -2.02M | -4.43M | -1.28M | 0.88M |
| Stock based compensation | - | 1.96M | 3.84M | 3.00M | 2.47M |
| Other non cash items | 3.77M | -0.11M | 11.64M | -0.43M | 0.13M |
| Free cash flow | -8.38M | -10.52M | -7.79M | -10.24M | -4.09M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ONE Oneview Healthcare Plc |
- -% |
0.12 | - | - | 9.48 | 11.18 | 5.92 | -3.52 |
| PME Pro Medicus Ltd |
-3.10 1.49% |
205.13 | 81.98 | 106.38 | 83.13 | 43.70 | 74.38 | 95.34 |
| 4DX 4DMEDICAL Ltd |
-0.13 5.39% |
2.28 | - | - | 205.57 | 8.53 | 170.03 | -7.29 |
| CGS Cogstate Ltd |
-0.09 2.66% |
3.29 | 33.80 | 27.86 | 9.59 | 6.95 | 6.35 | 19.27 |
| AYA ARTRYA Ltd |
- -% |
3.50 | - | - | 20505.14 | 7.00 | 16927.51 | 0.33 |
Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia. The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social. It also offers secure software development lifecycles, data classification, and third-party penetration testing services. The company was founded in 2008 and is based in Dublin, Ireland.
| Name | Title | Year Born |
|---|---|---|
| Mr. James Fitter | CEO & Exec. Director | NA |
| Ms. Helena D'Arcy | CFO & Company Sec. | NA |
| Mr. JP Howe | Chief Operations Officer | NA |
| Mr. Declan Bright | Chief Technology Officer | NA |
| Mr. John Kelly | Chief Financial Officer (Leave of Absence) | NA |
| Mr. Niall O'Neill | Chief Customer Officer | NA |
| Mr. Richard Eibrand | Head of Information Security and IT Operations | NA |
| Ms. Toni Pettit | Head of Learning & Devel. | NA |
| Mr. Colin Hackwood | Managing Director for Australia & New Zealand | NA |
| Mr. James Fitter | CEO & Executive Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.